메뉴 건너뛰기
Leukemia Research
Volumn 35, Issue 12, 2011, Pages 1547-1548
Plasmablastic lymphoma: Are more intensive regimens needed?
Author keywords

Hematopoietic stem cell transplantation; HIV negative; HSCT; PBL; Plasmablastic lymphoma
Indexed keywords

BORTEZOMIB; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;
EID: 80055110479     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.06.036     Document Type: Editorial
Times cited : (18)
References (7)
  • 1
    • 80055119570 scopus 로고    scopus 로고
    • Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review
    • Liu J.J., Zhang L., Ayala E., et al. Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leukemia Res 2011, 35:1571-1577.
    • (2011) Leukemia Res , vol.35 , pp. 1571-1577
    • Liu, J.J.1    Zhang, L.2    Ayala, E.3
  • 2
    • 78649276046 scopus 로고    scopus 로고
    • Clinical and pathological differences between HIV-positive and HIV-negative patients with plasmablastic lymphoma
    • Castillo J.J., Winer E.S., Stachurski D., et al. Clinical and pathological differences between HIV-positive and HIV-negative patients with plasmablastic lymphoma. Leuk Lymphoma 2010, 51:2047-2053.
    • (2010) Leuk Lymphoma , vol.51 , pp. 2047-2053
    • Castillo, J.J.1    Winer, E.S.2    Stachurski, D.3
  • 3
    • 53549113064 scopus 로고    scopus 로고
    • HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases
    • Castillo J., Pantanowitz L., Dezube B.J. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008, 83:804-809.
    • (2008) Am J Hematol , vol.83 , pp. 804-809
    • Castillo, J.1    Pantanowitz, L.2    Dezube, B.J.3
  • 4
    • 77953421580 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network [website]
    • NCCN Guidelines Version 3.2011: AIDS-related B-cell lymphoma. AIDS-3.
    • National Comprehensive Cancer Network [website]. NCCN Guidelines Version 3.2011: AIDS-related B-cell lymphoma. AIDS-3.
  • 5
    • 77950535702 scopus 로고    scopus 로고
    • Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma
    • Castillo J.J., Winer E.S., Stachurski D., et al. Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma. Oncologist 2010, 15:293-299.
    • (2010) Oncologist , vol.15 , pp. 293-299
    • Castillo, J.J.1    Winer, E.S.2    Stachurski, D.3
  • 6
    • 67650398258 scopus 로고    scopus 로고
    • Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
    • Dunleavy K., Pittaluga S., Czuczman M.S., et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 2009, 113:6069-6076.
    • (2009) Blood , vol.113 , pp. 6069-6076
    • Dunleavy, K.1    Pittaluga, S.2    Czuczman, M.S.3
  • 7
    • 80052980811 scopus 로고    scopus 로고
    • Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP {+/-} R for eight cycles to CHOP {+/-} R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL)
    • Stiff P.J., Unger J.M., Cook J., et al. Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP {+/-} R for eight cycles to CHOP {+/-} R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL). ASCO Meet Abstr 2011, 29:8001.
    • (2011) ASCO Meet Abstr , vol.29 , pp. 8001
    • Stiff, P.J.1    Unger, J.M.2    Cook, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.